Skip to main content
Caplight Logo









Celeris Therapeutics

Celeris Therapeutics

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://celeristx.com

Company Overview

Celeris Therapeutics is a biotechnology company that develops AI-driven degrader drugs for undruggable proteins linked to oncology and central nervous system disorders.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

targeted protein degradationdrug discoveryAI drug discoverycomputational biologysmall-molecule degradersPROTACsPICsundruggable targetsin silico drug designbiotech AIpharma R&Ddeep learningprotein degradationdrug discovery platformAI-first biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Celeris Therapeutics Comparables

Compare Celeris Therapeutics with similar companies based on industry and business-model similarity.

Celeris Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Plexium
84%
Ternary Therapeutics
81%
Neomorph
81%
View all Comparables

Celeris Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Celeris Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Celeris Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Celeris Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California
Year Founded2020
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?